BullFrog AI Believes It Has Regained Nasdaq Equity Compliance After Raising $3.45M, Mitigating Delisting Threat
BFRG has more than doubled off its 52-week low of $0.425.
Summary
BullFrog AI Holdings, Inc. announced it believes it has regained compliance with Nasdaq's minimum stockholders' equity requirement by raising at least $3.45 million through its ATM program and equity line of credit.
Key Events · Financing and Capital Events · BFRG
-
Regained Nasdaq Equity Compliance
The company believes it now has stockholders' equity exceeding $2.5 million, bringing it into compliance with Nasdaq Listing Rule 5550(b)(1), which requires a minimum of $2,500,000.
-
Capital Raise Through Existing Facilities
BullFrog AI completed sales of common stock under its at-the-market sales agreement and equity line of credit facility, generating aggregate net proceeds of at least $3.45 million.
-
Mitigates Delisting Threat
This action directly addresses the Nasdaq delisting notice received on August 21, 2025, and the going concern warning highlighted in the 10-K filed on March 19, 2026, by resolving the equity deficiency.
Analysis · BFRG · Life Sciences
This filing is a critical positive development for BullFrog AI, directly addressing the Nasdaq delisting threat and the going concern warning disclosed in the recent 10-K. By raising at least $3.45 million through its existing at-the-market program and equity line of credit, the company believes it has surpassed the $2.5 million minimum stockholders' equity requirement. This action significantly reduces the immediate risk of delisting and provides crucial capital, extending the company's operational runway. Investors should view this as a major step towards financial stability, though ongoing capital needs and operational performance remain key factors.
How filings like this one have moved
In the 30 days to Sep 30, 2026, 42.2% of the 325 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.39%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BFRG was trading at $1.58 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $19.9M. The 52-week trading range was $0.43 to $2.20. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.